Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 7Observational 1

Sponsor

Cancer Type

NET 1Gastrointestinal 1Endocrine 1

Conditions

Neuroendocrine Tumors 1Neoplastic Cells, Circulating 1Carcinoma, Hepatocellular 1

Interventions

Blood Specimen Collection 87Surveys and Questionnaires 80Surgical Procedures, Operative 54Observation 44Drug Therapy 44Bevacizumab 42Colonoscopy 41Biopsy 35Hepatectomy 33Capecitabine 27Neoadjuvant Therapy 26Immune Checkpoint Inhibitors 26regorafenib 25Interviews as Topic 25Radiotherapy 24Oxaliplatin 24Sorafenib 22Magnetic Resonance Spectroscopy 22lenvatinib 21Endoscopic Mucosal Resection 21Specimen Handling 18Immunohistochemistry 18Endoscopy 18Pancreaticoduodenectomy 17Liquid Biopsy 17Gastrectomy 17Endoscopic Ultrasound-Guided Fine Needle Aspiration 17Tomography, X-Ray Computed 16Gastroscopy 16Fluorouracil 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × lanreotide × Gastrointestinal × Clear all
NCT02973204 2021-04-28

Circulating Tumor Cells and Tumor DNA in HCC and NET

University of Aarhus

Completed
167 enrolled
EndocrineGastrointestinalNET

Carcinoma, Hepatocellular, Neoplastic Cells, Circulating, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡